<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Shuman, Jill</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">FitzGerald, John D.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Gout Guidelines: The Good, the Bad, and the Future</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">21-23</style></pages><abstract><style  face="normal" font="default" size="100%">A panel of 3 rheumatologists spoke of the challenges in developing and implementing the first-ever 2012 gout guidelines published in 2 parts by the American College of Rheumatology (ACR). Specific topics include an overview of the guideline development process, the new method adopted by the ACR to develop guidelines, as well as a discussion of the difficulties in implementing treatment guidelines.</style></abstract><number><style face="normal" font="default" size="100%">51</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>